PTBP1 and glioblastoma: PRGs showed a high sensitivity to mutation, with APOC1, NCAPG, FXYD1, and F2R mainly exhibiting heterozygous deletion in GBM, whereas PDE2A, BMP2, IFI30, and PTBP1 exhibited heterozygous amplification as the main CNV type.